174801-33-3 Usage
General Description
Tert-butyl (2S,3S)-1-(4-(benzyloxy)phenyl)-4-chloro-3-hydroxybutan-2-ylcarbamate is a complex chemical compound that belongs to the class of carbamates. It is a chiral compound with two stereocenters and a tert-butyl group attached to the nitrogen atom of the carbamate. The compound also contains a 4-chloro-3-hydroxybutyl chain and a benzyl ether moiety. This chemical may have potential applications in pharmaceuticals or organic synthesis due to its structural complexity and potential biological activity. However, further research and analysis are required to fully understand its properties and potential uses.
Check Digit Verification of cas no
The CAS Registry Mumber 174801-33-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,4,8,0 and 1 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 174801-33:
(8*1)+(7*7)+(6*4)+(5*8)+(4*0)+(3*1)+(2*3)+(1*3)=133
133 % 10 = 3
So 174801-33-3 is a valid CAS Registry Number.
InChI:InChI=1/C22H28ClNO4/c1-22(2,3)28-21(26)24-19(20(25)14-23)13-16-9-11-18(12-10-16)27-15-17-7-5-4-6-8-17/h4-12,19-20,25H,13-15H2,1-3H3,(H,24,26)/t19-,20+/m0/s1
174801-33-3Relevant articles and documents
Novel P1 chain-extended HIV protease inhibitors possessing potent anti-HIV activity and remarkable inverse antiviral resistance profiles
Miller, John F.,Brieger, Michael,Furfine, Eric S.,Hazen, Richard J.,Kaldor, Istvan,Reynolds, David,Sherrill, Ronald G.,Spaltenstein, Andrew
, p. 3496 - 3500 (2007/10/03)
A novel series of tyrosine-derived HIV protease inhibitors was synthesized and evaluated for in vitro antiviral activity against wild-type virus and two protease inhibitor-resistant viruses. All of the compounds had wild-type antiviral activities that were similar to or greater than several currently marketed HIV protease inhibitors. In addition, a number of compounds in this series were more potent against the drug-resistant mutant viruses than they were against wild-type virus.